TransEnterix, Inc. operates as a development stage medical device company. It focuses on research, development and sale of medical device robotics to improve minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling n August 19, 1988 and is headquartered in Morrisville, NC.
No unusual activity trades found. Try filtering by a different expiration or applying global filters to show complex (spreads, buy-write etc) & sold on the bid trades.